NEW YORK, July 31, 2024 /PRNewswire/ -- The global smart inhaler technology market size is estimated to grow by USD 46.37 million from 2023-2027, according to Technavio. The market is estimated to ...

Inhalers are used to treat chronic obstructive pulmonary disease (COPD), such as asthma, by delivering bronchodilator medication to the airway directly, without passing through the blood. COPD affects ...

The current report offers a comprehensive picture of the smart inhalers market.Smart inhalers prescribed for the treatment of asthma and COPD are included in the ...

The market for digital dose inhalers for asthma and COPD will be worth $3.56 billion in 2024, according to a new prediction from Grand View Research. Though connected inhalers are a new market, ...

Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in "the low eight figures", according to Opko's Director of Strategic Investment Les ...

Respiratory inhaler devices are essential tools for delivering medication directly into the lungs for the treatment and management of respiratory conditions such as asthma, chronic obstructive ...

The "Digital Dose Inhalers - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Digital Dose Inhalers is estimated at US$3.2 Billion in 2023 ...

Only 14.5 percent of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen and over 40 percent of academic pulmonary and allergy clinicians ...